Brain tumours in children are one of the most challenging diseases to treat, and so outcomes are variable and often lacking. There are currently no reliable data of presentation of disease, the spectrum of tumours treated, how these are treated, and what the outcomes are for children in South Africa, and certainly no molecular biology data. In this respect, this thesis investigated the two commonest types of childhood brain tumour, the highly malignant Medulloblastoma (MB) and the generally less aggressive Juvenile Pilocytic Astrocytoma (JPA) with relation to their molecular biology and their clinical correlates to begin to address this gap and build capacity for further molecular-based studies in an African context. The study design in thi...
CNS tumors are the leading cause of cancer-related death in children. Medulloblastoma is the commone...
There is a pressing need to identify therapeutic targets in tumors with low mutation rates such as t...
Medulloblastoma (MB) is the most common malignant pediatric brain tumor. Patient survival has remain...
Brain tumors represent the most frequent solid tumors occurring in pediatric age. Although their mor...
A top-down/bottom-up integrated proteomic approach based on LC-MS and 2-DE analysis was applied for ...
CNS tumors are the leading cause of cancer-related death in children. Medulloblastoma is the commone...
Medulloblastoma is the most common malignant brain tumor in children. Multimodality treatment regime...
Diagnosis and treatment of paediatric brain tumours has shown limited progress over the last half ce...
Medulloblastoma (MB) is the most common malignant brain tumor in children, where one-third of patien...
Medulloblastoma is the most common malignant brain tumor in children that is treated with surgery, c...
Medulloblastoma is the most prevalent malignant brain tumor in children, accounting for roughly 15% ...
Thesis: Ph. D., Massachusetts Institute of Technology, Department of Biological Engineering, 2019Cat...
Medulloblastomas and related primitive neuroectodermal tumors are the second most common malignant t...
Malignancies of the central nervous system are the leading cause of cancer-related death in children...
Medulloblastoma is the most common malignant pediatric brain tumour. Although survival rates have i...
CNS tumors are the leading cause of cancer-related death in children. Medulloblastoma is the commone...
There is a pressing need to identify therapeutic targets in tumors with low mutation rates such as t...
Medulloblastoma (MB) is the most common malignant pediatric brain tumor. Patient survival has remain...
Brain tumors represent the most frequent solid tumors occurring in pediatric age. Although their mor...
A top-down/bottom-up integrated proteomic approach based on LC-MS and 2-DE analysis was applied for ...
CNS tumors are the leading cause of cancer-related death in children. Medulloblastoma is the commone...
Medulloblastoma is the most common malignant brain tumor in children. Multimodality treatment regime...
Diagnosis and treatment of paediatric brain tumours has shown limited progress over the last half ce...
Medulloblastoma (MB) is the most common malignant brain tumor in children, where one-third of patien...
Medulloblastoma is the most common malignant brain tumor in children that is treated with surgery, c...
Medulloblastoma is the most prevalent malignant brain tumor in children, accounting for roughly 15% ...
Thesis: Ph. D., Massachusetts Institute of Technology, Department of Biological Engineering, 2019Cat...
Medulloblastomas and related primitive neuroectodermal tumors are the second most common malignant t...
Malignancies of the central nervous system are the leading cause of cancer-related death in children...
Medulloblastoma is the most common malignant pediatric brain tumour. Although survival rates have i...
CNS tumors are the leading cause of cancer-related death in children. Medulloblastoma is the commone...
There is a pressing need to identify therapeutic targets in tumors with low mutation rates such as t...
Medulloblastoma (MB) is the most common malignant pediatric brain tumor. Patient survival has remain...